NLS Pharmaceutics AG Tangible Net Worth Ratio
NLS Pharmaceutics AG tangible net worth ratio. NLS Pharmaceutics AG (NLSPW) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($2.88 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See NLSPW equity financing ratio to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of NLS Pharmaceutics AG (2021–2024)
Tangible net worth ratio of NLS Pharmaceutics AG from 2021 to 2024. This chart shows how NLS Pharmaceutics AG's Tangible Net Worth Ratio has changed across 3 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $2.88 Million with intangible assets of $0.00 USD. See working capital position of NLS Pharmaceutics AG to evaluate short-term liquidity relative to the company's equity base.
NLS Pharmaceutics AG Tangible Net Worth Ratio by Year (2021–2024)
NLS Pharmaceutics AG tangible net worth ratio by year from 2021 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for NLS Pharmaceutics AG from 2021 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see NLSPW company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $1.41 Million | $0.00 | $2.23 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $3.28 Million | $0.00 | $9.28 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $542.39K | $0.00 | $5.76 Million | — |